All Activity

Loved this piece about splimming and community! If anyone is looking for a fun way to stay active between sessions, check out this board that is Similar to Orbit Kick — great for cruising around town.

I definitely enjoying every little bit of it. It is a great website and nice share. I want to thank you. Good job! You guys do a great blog, and have some great contents. Keep up the good work. Go88 I definitely enjoying every little bit of it. It is a great website and nice share. I want to thank you. Good job! You guys do a great blog, and have some great contents. Keep up the good work. S8 I definitely enjoying every little bit of it. It is a great website and nice share. I want to thank you. Good job! You guys do a great blog, and have some great contents. Keep up the good work. Ao88 I definitely enjoying every little bit of it. It is a great website and nice share. I want to thank you. Good job! You guys do a great blog, and have some great contents. Keep up the good work. GEM88 I definitely enjoying every little bit of it. It is a great website and nice share. I want to thank you. Good job! You guys do a great blog, and have some great contents. Keep up the good work. kèo nhà cái I definitely enjoying every little bit of it. It is a great website and nice share. I want to thank you. Good job! You guys do a great blog, and have some great contents. Keep up the good work. Sunwin I definitely enjoying every little bit of it. It is a great website and nice share. I want to thank you. Good job! You guys do a great blog, and have some great contents. Keep up the good work. kèo trực tuyến I definitely enjoying every little bit of it. It is a great website and nice share. I want to thank you. Good job! You guys do a great blog, and have some great contents. Keep up the good work. Keovip.blog I definitely enjoying every little bit of it. It is a great website and nice share. I want to thank you. Good job! You guys do a great blog, and have some great contents. Keep up the good work. tỷ lệ kèo I definitely enjoying every little bit of it. It is a great website and nice share. I want to thank you. Good job! You guys do a great blog, and have some great contents. Keep up the good work. iwin08.ink I definitely enjoying every little bit of it. It is a great website and nice share. I want to thank you. Good job! You guys do a great blog, and have some great contents. Keep up the good work. Hitclub I definitely enjoying every little bit of it. It is a great website and nice share. I want to thank you. Good job! You guys do a great blog, and have some great contents. Keep up the good work. Gem88 I definitely enjoying every little bit of it. It is a great website and nice share. I want to thank you. Good job! You guys do a great blog, and have some great contents. Keep up the good work. Kèo nhà cái I definitely enjoying every little bit of it. It is a great website and nice share. I want to thank you. Good job! You guys do a great blog, and have some great contents. Keep up the good work. https://sunwinha.com.mx/ I definitely enjoying every little bit of it. It is a great website and nice share. I want to thank you. Good job! You guys do a great blog, and have some great contents. Keep up the good work. nhận định kèo I definitely enjoying every little bit of it. It is a great website and nice share. I want to thank you. Good job! You guys do a great blog, and have some great contents. Keep up the good work. Soi Kèo Bóng Đá I definitely enjoying every little bit of it. It is a great website and nice share. I want to thank you. Good job! You guys do a great blog, and have some great contents. Keep up the good work. Nhà cái uy tín I definitely enjoying every little bit of it. It is a great website and nice share. I want to thank you. Good job! You guys do a great blog, and have some great contents. Keep up the good work. keonhacai05.vip

High doses of THC from marijuana may have psychoactive effects that are hard to distinguish from those caused by the psychedelic psilocybin, according to a new study. The results, researchers said, could have implications for future clinical trials of psychedelics by helping to address the problem of “unblinding” where participants are able to tell whether they have received the drug being tested, a place or a comparator substance. That issued could potentially be avoided by administering cannabis products to participants in the non-psychedelic control group, the new paper indicates. The study, conducted by researchers with the Johns Hopkins University School of Medicine, involved four adults who underwent three or four sessions during which they were given either 25 milligrams of psilocybin, 25 milligrams of THC, 50 milligrams of THC or a placebo. The THC was administered either as a synthetic (dronabinol) or a whole-plant cannabis distillate extract. Participants were told that ketamine, dextromethorphan, (DMT) and (MDMA) could also be administered, but they weren’t actually used during the study. Both the participants and the facilitators of their sessions were blinded to what was actually received at the time, and they were asked to guess afterwards. Every participant was able to correctly guess when they had received a placebo or when they had received the real psychedelic. However, “the 25 mg dronabinol condition was rated as more similar to a classic psychedelic or dissociative than a cannabinoid, while the 50 mg distillate condition was perceived as predominantly sedative- or dissociative-like, but also moderately like a classic psychedelic by the one participant who received it,” the researchers wrote. “Both participants that received distillate correctly identified the 25 mg Δ9-THC dose as most similar to a cannabinoid and the participant that received the 50 mg Δ9-THC dose of distillate indicated that the drug was most similar to either a sedative or dissociative drug, with moderate similarity to a classic psychedelic, but rating the drug as having no similarity to a cannabinoid… While one participant with prior psychedelic use history rated 25 mg THC (distillate) as most similar to a cannabinoid, the other participant with prior psychedelic use history rated 25 mg THC (dronabinol) as most similar to a dissociative or psychedelic, suggesting that prior psychedelic use history alone did not completely determine subjective experience, blinding, or drug similarity assessments.” The whole-plant cannabis distillate extract of THC was rated by participants as having “a stronger overall subjective drug effect than equivalent doses” of the synthetic dronabinol, the paper, published in the journal Psychopharmacology, said. “25 mg Δ9-THC in both forms yielded a subjective experience similar to 25 mg psilocybin.” Prior experience with psychedelics “did not appear to significantly impact” participants’ being able to correctly differentiate the effects of cannabis and psilocybin, the researchers said. “These preliminary data suggest that a 25 mg oral dose of pure, synthetic Δ9-THC can be mistaken for a classic hallucinogen, and that oral Δ9-THC can elicit a psychedelic-like experience under set and setting conditions of a typical psychedelic clinical trial,” the study said. The researchers said that comparators used in psychedelic clinical trials to date “generally fail to preserve the blinding of drug administration due to the unique nature of psychedelic drug effects, including ‘mystical-type’ experiences.” The current results suggest that “an appropriate dose of Δ9-THC may provide an adequate active comparator condition for ongoing psychedelic clinical trials,” they said. The study was designed to mimic the set and setting in which psychedelic research is typically carried out. Participants laid on a couch, wore eye shades, listened to music and were told to “turn inward and be present for whatever arises within consciousness.” “High-dose cannabis can produce psychedelic-like states.” The general lack of ability of some participants to distinguish between the effects of the substances tested demonstrates that “Δ9-THC can produce substantial alterations in consciousness under optimized set and setting and may offer a viable component in the development of improved active-control conditions in psychedelic research,” the researchers wrote. “This pilot investigation provides preliminary evidence that oral Δ9-THC, when administered under the set and setting conditions of a typical psychedelic clinical trial, can occasion subjective effects with phenomenological overlap with those of psilocybin. Subjective effects and blinding outcomes indicate that an appropriate dose of THC may partially reduce functional unblinding relative to placebo and other active comparators in randomized clinical trials.” The study was funded by the Wana Brand Foundation, which was launched by the CEO of the cannabis company Wana Brands. Image element courtesy of Kristie Gianopulos. The post High Doses Of THC From Cannabis Can Produce ‘Psychedelic-Like States,’ Study Shows appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Try this website to decode your destiny: BaziCalculator.ai

Not just visitors, but people living in the area also prefer an acquaintance who is well-dressed and courteous. This is the main reason why High Class Escorts in Noida have always been admired. They possess great style and courtesy, and their presence adds value and a sense of comfort to the occasion while ensuring discretion, attractiveness and professionalism. The general feel of the occasion is of privacy, respect, and warmth and happiness; thus transforming a boring and usual evening.

House vote on hemp ban delay; KY gov pushes Congress not to ban THC products; LA marijuana penalties; Study: Medical cannabis for people with cancer Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day. Get our daily newsletter. Email address: Leave this field empty if you're human: Your support makes Marijuana Moment possible… Free to read (but not free to produce)! We’re proud of our newsletter and the reporting we publish at Marijuana Moment, and we’re happy to provide it for free. But it takes a lot of work and resources to make this happen. If you value Marijuana Moment, invest in our success on Patreon so we can expand our coverage and more readers can benefit: https://www.patreon.com/marijuanamoment / TOP THINGS TO KNOW Marijuana Moment obtained a list of 26 questions that the Drug Enforcement Administration is sending to Colorado medical cannabis businesses that applied for federal protections in line with the Trump administration’s rescheduling move. “Will you be ordering marijuana or marijuana products from other states?” The House of Representatives is expected to take up Senate-passed legislation to delay the scheduled federal recriminalization of hemp THC products on Tuesday—giving lawmakers more time to craft regulations as an alternative to prohibition. Kentucky Gov. Andy Beshear (D) said “hemp is really important” to the state and that voters should defeat any members of Congress who are trying to keep the scheduled federal recriminalization of hemp THC products on track for November. “People should look for an alternative to the current person who would vote yes on something like that.” Louisiana Gov. Jeff Landry (R) is asking schools to help publicize a new law he signed that threatens to send people to jail for up to one year if they smoke marijuana within 2,000 feet of a school property—including college campuses. “The zone extends two thousand feet past the property line, so it covers streets, sidewalks, bus stops, parks, and homes that students do not think of as school property.” A new federally funded study found that “cannabis use conferred therapeutic benefits for several health issues commonly encountered by cancer patients”—with researchers saying the results highlight “the need for insurance coverage of medicinal cannabis to reduce the financial burden for this patient population.” / FEDERAL The U.S. Department of Agriculture’s Risk Management Agency is updating hemp provisions of crop insurance policies to remove references to “industrial” and “delta-9.” Sen. John Cornyn (R-TX) responded to a tweet from a Texas district attorney who had said, “Are we ready to admit we’ve lost the war on drugs yet?” by asking, “All drugs?” / STATES An Oklahoma representative authored an op-ed urging Congress not to reverse the planned federal recriminalization of hemp THC products. New York regulators published guidance about state-paid cannabis tracking inventory tags. Vermont regulators adopted updated cannabis advertising guidance. Washington State regulators will consider petitions to change various cannabis rules on Wednesday. The Michigan Cannabis Regulatory Agency will hold a public meeting on September 24. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — / INTERNATIONAL Costa Rica’s first medical cannabis manufacturing lab opened. / SCIENCE & HEALTH A study of patients with seizures found that they “thought medical cannabis was beneficial, but not that affordable and often chose cannabis products that contained THC.” / ADVOCACY, OPINION & ANALYSIS Eagle Forum’s president authored an op-ed urging Congress not to delay the federal recriminalization of hemp THC products. / BUSINESS Headset Inc. agreed to pay more than $1 million to resolve allegations it improperly received a Small Business Administration Paycheck Protection Program loan it was ineligible for due to its work in the marijuana industry. Ascend Wellness Holdings, Inc. shareholders approved a reverse stock split that is intended to position the company to list on a major U.S. exchange. Colorado retailers sold $107.5 million worth of legal marijuana products in May. Make sure to subscribe to get Marijuana Moment’s daily dispatch in your inbox. Get our daily newsletter. Email address: Leave this field empty if you're human: Photo courtesy of Mike Latimer. The post DEA’s list of cannabis questions for businesses seeking rescheduling protections (Newsletter: September 1, 2026) appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

I am continually amazed by the amount of information available on this subject. What you presented was well researched and well worded in order to get your stand on this across to all your readers. jnetoto

I am jovial you take pride in what you write. It makes you stand way out from many other writers that can not push high-quality content like you. jnetoto

If more people that write articles involved themselves with writing great content like you, more readers would be interested in their writings. I have learned too many things from your article. naga303.co.com

California’s governor has signed a bill to more clearly define the types of marijuana packaging and labeling that is prohibited due to appealing to children. Gov. Gavin Newsom (D) gave final approval to the legislation from Assemblymember Jacqui Irwin (D) on Monday, about two weeks after it passed the Assembly in a vote of 69-1 and cleared the Senate 38-0. “When voters legalized adult-use cannabis, they also made clear that California must protect children and ensure cannabis products are sold in a tightly regulated marketplace,” the governor said in a press release. “Today we are setting clearer, enforceable standards that protect kids, strengthen accountability, and give responsible businesses the certainty they need to follow the rules.” As enacted into law, AB 2249 defines “attractive to children” to mean designed or likely to appeal to people under the age of 21. Indications for that youth appeal include the use of cartoons, depictions of individuals who appear to be under 21, use of mythological creatures like unicorns or dragons or references to celebrities or characters who are primarily associated with children’s entertainment. It also includes images of consumable goods that are primarily marketed to children—such as candies, cereals, sweets and desserts—as well as the use of lettering styles resembling “overinflated bubbles or balloons” that are typical in products marketed to kids. “Cannabis and cannabis product packaging and labeling shall not imitate, mimic, or closely resemble the packaging, labeling, trade dress, or overall appearance of a non-cannabis product that is primarily marketed to children,” the legislation says. While the new law says that “edible cannabis product or vape cartridge labeling shall not include cartoon or overly stylized depictions of fruit,” one provision clarifies that “realistic depictions of fruit used to identify or accurately depict the product ingredients or production region are not prohibited.” The packaging and labeling restrictions are set to take effect on January 1, 2028 now that the measure has been enacted into law. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — Under the legislation, the Department of Cannabis Control (DCC) is directed to adopt regulations to “address additional packaging and labeling design elements or product characteristics that pose heightened risk to children.” DCC will also be required to develop “compliance assessment resources” to help cannabis businesses self-evaluate whether their packaging and labeling at attractive to children. In June, the department rolled out a new AI tool to help businesses identify marijuana product packaging may appeal to kids in violation of existing state rules, which already ban cartoons on cannabis labels. Irwin, the bill’s sponsor, previously requested the California State Auditor to conduct an assessment of DCC’s enforcement of existing laws against marketing cannabis products to children. That audit “confirmed what many have long recognized: California’s cannabis industry continues to package and market products in ways which are overtly attractive to children,” the lawmaker said. “Since the passage of Proposition 64, child cannabis poisonings have increased dramatically. These exposures are often driven by cannabis product packaging that uses features which are explicitly attractive to children, leading children to consume the products unintentionally,” Irwin said. “Young children who accidentally consumer cannabis require poison control treatment consistently, and in many cases they can also expose their fellow elementary and middle school peers to cannabis.” The California Cannabis Industry Association (CCIA), for its part, opposed the bill. “AB 2249 would impose significant costs on the licensed businesses that already keep cannabis away from children, undermine the state’s efforts to bring consumers into the regulated market, and does not address safe at-home storage practices,” the trade association said. The measure was amended by the Senate after initially clearing the Assembly, including by delaying its effective date, narrowing the definition of “attractive to children” and removing some requirements for regulators. Meanwhile, lawmakers this session have also advanced legislation to allow marijuana retailers to offer drive-thru windows to serve customers. California’s treasurer recently said the marijuana legalization law that voters approved a decade ago has been a “complete failure” and should be replaced with a new ballot initiative that prioritizes consumers and small businesses. The vice chair of the state Senate Budget Committee has floated the idea of putting a new initiative on the state ballot to “reverse” Proposition 64, for example, arguing that voters were misled and voicing concerns about the health impacts of marijuana use. Republican gubernatorial candidate Steve Hilton, who is endorsed by President Donald Trump, recently told Marijuana Moment that taxes and regulations on cannabis are “too high.” DCC recently released data showing how 97 percent of state cannabis enforcement actions in unincorporated cities have happened in counties that have locally banned licensed growers from operating. California regulators also recently adopted emergency rules changes for the state’s marijuana licensing process that are intended to make it easier for businesses to qualify for benefits in line with the Trump administration’s recent move to federally reschedule medical cannabis. Newsom recently took credit for helping to lead the push for the state to legalize marijuana and discussed his own limited experience with using cannabis. Last October, however, Newsom vetoed a bill that would have allowed certain marijuana microbusinesses to ship medical cannabis products directly to patients via common carriers like FedEx and UPS, stating that the proposal “would be burdensome and overly complex to administer.” Newsom did sign a bill earlier that month aimed at streamlining research on marijuana and psychedelics. Last September, the governor also signed a measure into law to put a pause on a recently enacted tax hike on marijuana products. Separately, the state attorney general says Indian tribes cannot independently engage in marijuana commerce with licensed cannabis businesses without first obtaining their own commercial license from state officials. California officials recently awarded nearly $30 million in grants for marijuana-focused academic research projects. The post California Governor Signs Bill Restricting Marijuana Packaging That’s ‘Attractive To Children’ appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

This is a great step forward for cannabis businesses - access to banking has been one of the biggest hurdles for legal operators. Hopefully the Senate moves on it soon. By the way, if anyone here enjoys riding around town, check out Summer Rider for some fun gear.

Louisiana’s governor is asking schools to publicize a new law he signed that threatens to send people to jail for up to one year if they smoke marijuana within 2,000 feet of a school property—including a college campus. The legislation that Gov. Jeff Landry (R) signed in May applies to people who violate drug laws “while smoking, vaping, or otherwise abusing such controlled dangerous substance while on any property used for school purposes by any school, within two thousand feet of any such property, or while on a school bus.” In a letter to the executive director of the Louisiana High School Athletic Association, the governor is asking the organization to “make its member schools aware of this change now, and to ask them to carry it to their student-athletes, coaches, event staff, and fans.” “Fall sports are underway, and on most Friday nights thousands of students, parents, and other spectators gather on and around school campuses across Louisiana,” he wrote. The enhanced cannabis penalty zone “extends two thousand feet past the property line, so it covers streets, sidewalks, bus stops, parks, and homes that students do not think of as school property,” Landry said, adding that it applies to “any person, not only students.” “A parent, an alumnus, or any other spectator who smokes or vapes marijuana in a stadium parking lot, at a tailgate, or in the stands during a contest is exposed to the same penalty as a student,” he said. “The same analysis applies to contests played away from a member school’s own campus whenever the host site is a school or sits within two thousand feet of one.” The governor emphasized that the consequences of a marijuana arrest at a school sports game “do not stop at the courthouse.” “A student arrested for a felony-grade offense carries a criminal record, and questions about eligibility and college recruitment follow, all for conduct that was a citable offense last spring. Adult spectators face the same criminal exposure. Member schools are better served by making this known before the first incident than by explaining it afterward.” Landry provided a flyer he wants schools to display about the new penalties, asking them to post it “where students and spectators gather at athletic facilities, including gymnasiums, field houses, locker rooms, concession areas, and stadium and gate entrances.” IMPORTANT INFO FOR BACK TO SCHOOL AND FOOTBALL SEASON: Marijuana on campus is a crime. Act 305 set new penalties of up to one year in prison, plus a $1,000 fine for possession of marijuana in a school zone. pic.twitter.com/OXO5iTSGxK — Governor Jeff Landry (@LAGovJeffLandry) August 31, 2026 “The people who will handle these incidents should be briefed,” he said in the letter, which was first reported by WGNO-TV. “Athletic directors, coaches, game administrators, event security, gate and ticket staff, bus operators, contest officials, and school resource officers assigned to events should understand the new penalty before they encounter it, because an arrest for conduct that was a citable offense last spring now exposes a student or a spectator to a felony sentence.” In June, Landry posted a video saying he signed the marijuana penalty bill because he is “tired” of smelling cannabis at football games. “Like most of you, I’m tired of going to our college and high school campuses and being inundated with the smell of marijuana,” he said. “And I’m tired of seeing drugs littering our high school and college campuses, hurting our students.” “These drugs take away from the family-friendly environments that our colleges are supposed to be, especially on game days,” the governor said. Landry’s staff previously testified in favor of the legislation at a committee hearing. Rep. Gabe Firment (R), who sponsored the bill, said that it “strengthens enforcement of Louisiana drug-free school zone laws by creating a clear behavior-based offense, so that when someone is openly smoking or vaping illegal drug in the school zone, law enforcement can act and prosecutors can prove the case.” “For marijuana, the bill establishes a clear and consistent penalty—up to a year in jail and $1,000 fine, ensuring that violations in school zones result in real, enforceable consequences,” he said. Kevin Caldwell of the pro-legalization Marijuana Policy Project (MPP), said the group is “disappointed to see this deeply flawed legislation become law with the signature of Gov. Jeff Landry.” “His personal lobbying efforts forced many legislators to vote for a bill they know will have profound negative life altering consequences for potentially thousands of Louisianans,” Caldwell told Marijuana Moment. “His solution to every perceived problem has been a return to incarceration. These failed policies of the past should remain in the past.” “No child in Louisiana will be any safer after this legislation goes into effect,” he said. “But historical data clearly shows who will bear the brunt of this policy. The governor and legislature are seriously out of touch with the people of Louisiana.” In 2021, then-Gov. John Bel Edwards (D) signed a bill decriminalizing marijuana by removing the threat of jail time for possessing up to 14 grams. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — Meanwhile, a Louisiana bill to let patients with terminal and irreversible conditions use medical marijuana in hospitals took effect without Landry’s signature. Separate legislation to create a psychedelic-assisted therapy pilot program, using opioid settlement dollars to fund clinical trials aimed at developing alternative treatments such as psilocybin, ibogaine and MDMA also took effect without the governor’s support. Also this session, a lawmakers filed a proposal that would have created a new state task force to “study and develop findings and recommendations regarding the potential legalization of recreational marijuana.” Another lawmaker also introduced a bill to create an adult-use marijuana legalization pilot program in the state to determine whether the reform should eventually be expanded and permanently codified. The post Louisiana Governor Asks Schools To Publicize New Marijuana Penalties That Will Jail People For Smoking Near Campuses appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Quitting the nightly wine habit is such a tough shift, so congrats on sticking with it! I've found the real trick is having something else to wind down with in the evening — sometimes it's herbal tea, sometimes it's just keeping my hands busy with a casual game. Lately I like to play Wacky Steps online before bed instead of pouring a glass. Drinkable CBD is an interesting route too, glad it's been working for you.

A new federally funded study sheds light on cancer patients’ use of medical marijuana and how symptom relief differs based on the THC and CBD content of the cannabis products they are using. Researchers said that the results, which also shed light on barriers to access such as high costs, underscore the “need for insurance coverage of medicinal cannabis.” “Cannabis use conferred therapeutic benefits for several health issues commonly encountered by cancer patients,” the paper, published in the journal Frontiers in Psychiatry, said. “Common benefits reported across the cohort of patients included pain relief, improved sleep, physical relaxation, emotional regulation, and reduction of concomitant medication.” Researchers at the University of Wisconsin, University of Pennsylvania, Johns Hopkins University and Realm of Caring Foundation surveyed 65 patients with cancer who use cannabis, asking about the types of products they consume, the perceived benefits on their symptoms and any negative impacts. They then compared those who use CBD-dominant preparations only with those who used products containing both THC and CBD, finding that symptom relief differed between the two groups. While “pain relief was the most frequently discussed benefit among all cancer patients” in the study, it was most prominent among those who used THC and CBD products—whereas “emotional regulation was more prominent in only the users of CBD-only products,” the researchers wrote. “Pain relief, emotional regulation, sleep or physical relaxation, and medication reduction emerged as benefits experienced by cancer patients in both CBD-only and CBD+THC exposure groups.” In addition to looking at what symptoms were relieved by cannabis, the study also examined the “interconnected nature” of perceived benefits between different symptoms and how those connections differed among patients who used CBD only as compared to those who also used THC products. Pain relief, for example, was most strongly connected in the CBD-only group to emotional regulation, reduction in use of other medications, improvements in sleep or physical relaxation and appetite stimulation—in that order. For the group that also used THC, pain relief was most often connected, in descending order, to sleep or physical relaxation, emotional regulation, medication reduction and appetite stimulation. For the CBD-only group, emotional regulation, sleep and physical relaxation were all strongly interrelated, which the researchers said “affirms existing literature showing that CBD reduces anxiety, improves mood, and promotes relaxation, possibly by modulating serotonin and anxiety-regulating pathways, including the hypothalamic-pituitary-adrenal axis.” The study, which was funded by the National Cancer Institute, the National Institute on Drug Abuse and the Realm of Caring Foundation, also asked cancer patients about any difficulties in accessing cannabis. “The most frequently reported barriers to cannabis use were the stigma associated with THC use and the high cost of CBD-dominant and THC-dominant products,” the researchers wrote. “This study highlights the continued perception of stigma associated with THC use and the need for insurance coverage of medicinal cannabis to reduce the financial burden for this patient population.” The paper concluded by noting limitations of the study, such as its self-selection and self-report bias and that there was no laboratory verification of the products patients used. “Future research with larger, more diverse samples should incorporate objective measures of cannabinoid efficacy and investigate long-term outcomes,” the researchers wrote. “Additionally, exploring the differential effects of specific cannabinoid formulations could refine therapeutic approaches. Future research should compare current versus former cannabis users and should ideally include a non-cannabis-using control group with a larger sample in a randomized trial.” Overall, however, the current results showed that “pain relief was the most frequently discussed benefit and was associated with other benefits: emotional regulation, sleep or physical relaxation, and medication reduction.” The research adds to a growing body of evidence showing that cancer patients and survivors are using cannabis to manage symptoms. For example, a recent study found that nearly one in five cancer survivors say they’ve used CBD after getting their diagnosis—primarily to manage pain, sleep difficulties and emotional distress. And more than half of those who used it for specific symptoms reported at least some benefit. Another recent study determined that medical marijuana extracts “meaningfully” improve cancer-related symptoms such as sleep difficulties and anxiety—though responses varied among patients depending on personal preferences for individual cannabinoid content of the extracts. Researchers separately found that components of marijuana show “consistent and statistically significant anti-tumor effects” in certain types of cancer, including glioblastoma and breast cancer. The study also showed that cannabinoids seem to “enhance chemotherapy efficacy.” Another systemic review concluded that studies “consistently show” that the CBD is a potential “anticancer agent across different cancer types”—and that effect applies to dogs as well as humans. A similar analysis showed that CBD “holds substantial promise as an anti-tumor agent” in addition to its other anti-inflammatory properties. Scientists explored CBD’s effect on many types of cancer—including some of the most aggressive ones, such as glioblastoma, which affects the brain. They also noted it can help suppressing the growth and metastasis of other cancers, including breast, lung, colorectal, ovarian and prostate, among others. In 2025, a paper published in the journal Pharmacology & Therapeutics, assessed a range of clinical and preclinical findings that the efficacy of chemotherapy drugs can be enhanced by medical marijuana. In a sign of greater acceptance of medical applications of cannabis, President Donald Trump’s choice to serve as the next White House drug czar has called medical marijuana a “fantastic” treatment option for seriously ill patients and said she doesn’t object to legalization, even if she might not personally agree with the policy. Also last year, a study found that “patients with cancer using cannabis report significant improvements in cancer-related symptoms.” The post Federally Funded Cancer Study Highlights Need To Cover Medical Marijuana Under Insurance, Researchers Say appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

The U.S. House of Representatives is expected to consider a bill this week that contains provisions to delay the federal recriminalization of hemp THC products that is currently scheduled to take effect in November. The legislation, which has already been approved by the Senate, is intended to give lawmakers more time to craft regulations as an alternative to prohibition. The Senate-passed provision is part of legislation to keep the federal government funded through December 11, past the end of the current fiscal year on September 30. If enacted into law, the effective date of the hemp product ban would also be moved to December 11. The Senate earlier this month rejected an amendment from Sen. Ted Budd (R-NC) and several cosponsors that would have removed the hemp ban delay provision from the funding bill, tabling it in a vote of 61-32, and the passing the overall legislation 90-6. Leadership in the House has indicated the body will take up the measure on Tuesday under an expedited process known as suspension of the rules that does not allow for amendments and requires a two-thirds supermajority for passage. Hemp derivatives with less than 0.3 percent delta-9 THC on a dry-weight basis were federally legalized under the 2018 Farm Bill that President Donald Trump signed during his first term in office. But late last year, the president signed new legislation containing provisions that will redefine hemp to make it so only products with 0.4 milligrams of total THC per container will remain legal after November 12. The funding bill’s provision to delay the ban, which is supported by the White House, contains a carve-out to allow the immediate recriminalization on November 12 of synthetic cannabinoids “that are not capable of being naturally produced by a Cannabis sativa L. plant.” Centers for Medicare and Medicaid Services Director Mehmet Oz sent a letter to senators expressing “grave concern” that the amendment to remove the delay would undermine the administration’s initiative to cover hemp-derived products through Medicare. Separately, the White House pushed back on the idea that the president’s support for keeping hemp products legal is intended to benefit the son-in-law of Trump’s chief of staff, who owns businesses in the industry—with a spokesperson saying that the administration’s advocacy is in “the best interest of the American people” and is aimed at helping veterans and other people who use hemp products for medical purposes. During a “tense” meeting with Senate Republicans about the issue, White House Director of Legislative Affairs James Braid reportedly committed that there would be no further extensions of the hemp ban’s effective date if the current proposal was enacted into law, though it was reported soon after that the staffer would be leaving the administration in September. Dueling coalitions of police, military veterans and industry groups sent letters pushing Congress in different directions on whether the planned federal recriminalization of hemp THC products should move forward as scheduled or be delayed. Additionally, a bipartisan coalition of 35 state and territory attorneys general sent a letter calling on Congress not to reverse the hemp THC product ban, saying that lawmakers’ move to enact the forthcoming prohibition “protected consumers, provided much-needed regulatory clarity, and preserved legitimate industrial, agricultural, and nonintoxicating hemp markets.” The Beverage Alcohol Merchants Coalition (BAMCO), which represents major alcohol retailers, is supporting the move to delay the hemp product ban—saying it provides industry supporters with more time to convince Congress to “establish a responsible federal framework for low-dose hemp-derived THC beverages.” BAMCO’s members include Total Wine & More, BevMo! by Gopuff, ABC Fine Wine & Spirits, Spec’s Wine and Spirits & Finer Foods, as well as a group of hemp product wholesalers. The group supports incorporating hemp THC drinks into the existing three-tier system for alcoholic beverages, along with new requirements for testing, labeling, marketing and taxation in tandem with flexibility for state regulations. Other alcohol industry groups such as Wine & Spirits Wholesalers of America have also backed regulating hemp products instead of prohibiting them. A number of lawmakers from both chambers and both parties have filed or are circulating a growing number of bills to prevent the scheduled federal recriminalization of hemp THC drinks and other products later this year. Until now, none of those proposals have gained traction with congressional leaders. For example, Reps. Beth Van Duyne (R-TX) and Greg Landsman (D-OH) filed a bill to keep hemp THC drinks legal while taxing and regulating them like alcohol. Rep. James Comer (R-KY), who chairs the House Oversight and Government Reform Committee, is circulating legislation that would delay a planned federal ban on hemp THC products and institute some regulations—including packaging requirements, testing rules and age limits. Separately, Rep. Andy Barr (R-KY), filed a lengthier proposal to prevent the federal recriminalization of hemp THC products and put in place a number of regulations for manufacturing, labeling, sales and taxation of hemp-derived products, including an age limit of 21. Trump and White House officials have in recent weeks repeatedly pressed Congress to delay, alter or reverse the ban. In a letter to House Speaker Mike Johnson (R-LA) in June, for example, White House Office of Management and Budget (OMB) Director Russell Vought said the Trump administration wants lawmakers to “ensure the fair treatment of hemp products”—specifically citing Barr’s earlier amendment to keep many hemp products legal while adding regulations and taxes. The administration “welcomes the opportunity to work with the Congress to, at a minimum, update the statutory definition of final hemp-derived cannabinoid products to allow Americans to benefit from access to appropriate full-spectrum CBD products,” OMB separately said in June, “while preserving the Congress’s intent to restrict the sale of products that pose serious health risks.” Also in April, the president himself urged congressional lawmakers to again redefine hemp to avoid recriminalization of full-spectrum CBD products. “I am calling on Congress to update the Law to ensure that Americans can continue to access the full-spectrum CBD products they have come to rely on, and that help them, while preserving Congress’s intent to restrict the sale of products that pose Health risks,” Trump said in a Truth Social post. “We must get this done RIGHT and FAST, especially for those who saw that CBD helps them,” he said. “Plus, I am told it will also help our GREAT FARMERS, who we love, and will always be there for.” Industry advocates say that the law as enacted last year not only threatens to prohibit intoxicating and synthetic cannabinoid products but also stands to remove popular full-spectrum CBD products that many Americans use therapeutically from the market. “ONE in FIVE adults used it in the past year, and many say it improved their chronic pain enormously,” the president said in his social media post, adding that hemp-derived CBD “has made a HUGE difference for so many people.” He also referenced a new initiative the administration launched in April to cover up to $500 worth of hemp-derived products each year for eligible Medicare patients. The program being implemented by the Centers for Medicare & Medicaid Services (CMS) focuses largely on CBD but also allows products to have up to 3 milligrams of total THC per serving. A federal judge granted the government’s motion to dismiss marijuana legalization opponents’ lawsuit challenging the initiative, but that is being appealed. “In December, I signed a very important Executive Order calling for Research and Innovation for Hemp-derived CBD,” Trump said. “Our wonderful Dr. Mehmet Oz moved fast to follow the directive in the Executive Order, and launched a model for some Seniors earlier this month. But more must be done!” “Please get it done, and SOON,” the president said in reference to a congressional fix for the broad recriminalization set to take effect in November. “Thank you for your attention to this matter!” The Wine & Spirits Wholesalers of America (WSWA), an alcohol industry trade association issued praise for Barr’s bipartisan hemp regulation bill, but said the measure’s tax provisions require “continued discussion.” Hemp policy observers expect to see a Senate companion bill to Barr’s proposal filed soon, likely from Sens. Tim Sheehy (R-MT) and Amy Klobuchar (D-MN). Sheehy recently cited hemp legislation as an area where Republicans and Democrats can work together in an otherwise “hyperpartisan time.” — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — Meanwhile, a new poll from NuggMD found that most cannabis consumers say that state-level hemp product bans that lawmakers are enacting in line with the planned federal recriminalization move are causing them to shift their purchases toward licensed marijuana businesses. The National Restaurant Association recently sent a letter urging congressional leaders to delay the federal recriminalization of hemp THC beverages and replace it with a regulatory framework that “ensures consumer safety while meeting growing market demand” for the products as an alternative to alcohol. Major retailer Target, meanwhile, recently moved to expand its sales of hemp THC drinks into more states. The post House To Vote On Delaying Hemp THC Ban This Week, Giving Lawmakers More Time To Craft Regulations To Keep Products Legal appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

The governor of Kentucky says that hemp is “important” to the state, and voters shouldn’t reelect any members of Congress who are seeking to ban it. “Hemp is really important to Kentucky. It supports a lot of Kentucky farmers, and there are positive uses of hemp,” Gov. Andy Beshear (D) said at a press conference on Thursday. “Do we need to make sure that children are protected from the delta-8 or other products? Yes, but we, as a [state] government, ought to be able to do that.” Hemp derivatives with less than 0.3 percent delta-9 THC on a dry-weight basis were federally legalized under the 2018 Farm Bill that President Donald Trump signed during his first term in office. But late last year, the president signed new legislation containing provisions that will redefine hemp to make it so only products with 0.4 milligrams of total THC per container will remain legal after November 12. That said, Senate recently approved a funding bill that includes a provision to delay the effective date of most parts of the hemp product ban until December 11—a move that was supported by the White House. While that change has not yet been approved by the House of Representatives or enacted into law, industry supporters believe it could give them more time to convince Congress to enact a regulatory structure for hemp products as an alternative to broad prohibition. Beshear said that the currently planned ban on hemp THC product would “decimate the hemp industry.” “I do not support it,” he said. “Give states the ability to to fully and fairly regulate it. We’ll protect kids or put a reasonable structure in place, but don’t hurt Kentucky farmers who are already struggling.” The governor asked listeners to think about a soybean farmer who is considering growing hemp because their current operation is “getting hammered” by the impact that tariffs and the Trump administration’s war with Iran are having on diesel fuel and fertilizer prices. “If we are going to eliminate another product you could grow, then the federal government’s actions or Congress’s actions towards Kentucky farmers is just devastating,” Beshear said. “And people should look for an alternative to the current person who would vote yes on something like that.” The comments on hemp came at the same press conference at which the governor also said the state’s efforts to get medical cannabis dispensaries open is now past the “halfway mark” to becoming “fully operational.” The governor, who signed medical cannabis legalization legislation in 2023 that took effect at the beginning of last year, said he is “proud” that the state is “moving forward in every step of the process.” “So far, more than 25,209 Kentuckians have been approved for medical cannabis cards,” he said. “We now have over 490 practitioners registered to issue certifications. And we have 41 businesses up and running. That includes 11 cultivators, two safety compliance facilities, five processors and 23 dispensaries. Those numbers will continue to grow.” The increasing access to medical marijuana means that “more Kentuckians won’t have to turn to addictive opioids” and will be able to “deal with chronic conditions, will get the relief they deserve, will be able to to address the PTSD that they may have gotten while serving our country.” With the Blue Sage Dispensary opening in Lebanon on Friday, Beshear said, the state will be “over the halfway mark of Kentucky becoming fully operational when it comes to dispensaries.” “Medical cannabis is helping our people in need live fuller lives with less pain,” the governor said. “It is a win-win.” Beshear signed an executive order in June to broaden the list of health conditions that make patients eligible to legally obtain medical cannabis. But days later, House Majority Whip Jason Nemes (R) asked Attorney General Russell Coleman (R) to ensure that state agencies “not cooperate” with the governor’s marijuana directive, which he called “unlawful.” “Any organization, any licensee, that participates in this unlawful expansion should be prosecuted,” Nemes said during a legislative committee hearing. “This is not the way forward.” The governor pushed back, however, saying that the GOP lawmaker exhibited a “complete lack of humanity.” “It’s helping a lot of people, and I was really surprised to see an attack from one lawmaker who called on the attorney general to prosecute people dying of a terminal illness for securing medical cannabis,” Beshear said. “I mean, that’s a complete lack of humanity. It is really low. I mean, an individual with ALS, you want to prosecute? That is certainly not leadership, and even for that individual, is a new record low.” After the legislature declined to take him up on a suggestion to expand the qualifying condition list this session, the governor used his authority to make it so patients with 15 additional health disorders—including Parkinson’s disease, HIV/AIDS, sickle cell anemia, fibromyalgia, arthritis and glaucoma—can also be certified for medical marijuana access. Beshear also rescinded an earlier executive order he issued in 2022 through which he offered to provide pardons for any patients who got into trouble for possessing medical cannabis that they purchased at a legal dispensary in a neighboring state. The more recent executive order on qualifying conditions is a follow up to a medical marijuana legalization law Beshear signed in 2023. The state’s first medical cannabis dispensary opened in December of last year. The governor in February announced that cannabis gummies are available for purchase in the state’s licensed dispensaries. Beshear in January said he’s “not satisfied” with the time it’s taken to launch the state’s medical marijuana program—but that he anticipates the pace of patient access would “pick up significantly” in 2026. In recognition of the delayed implementation, he signed an executive order to waive renewal fees for patients who get their cards so that they don’t get charged again before retailers open. Beshear separately announced last year that the state had launched a new online directory that lets people see where medical cannabis dispensaries will be opening near them. He emphasized that the state has been working to deliver access to patients “at the earliest possible date,” and that involved expediting the licensing process. Last year, the governor also ceremonially awarded the commonwealth’s first medical marijuana cards. During the November 2024 election, Kentucky also saw more than 100 cities and counties approve local ordinances to allow medical cannabis businesses in their jurisdictions. The governor said the election results demonstrate that “the jury is no longer out” on the issue that is clearly supported by voters across partisan and geographical lines. Meanwhile, legislature’s Interim Joint Committee on Health Services held a hearing last month on a proposal to allow terminally ill patients to use medical marijuana in hospitals. The post There Are ‘Positive Uses’ Of Hemp And Congress Shouldn’t Ban It, Kentucky Governor Says appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

The Drug Enforcement Administration (DEA) wants to know whether medical marijuana businesses seeking federal protections in line with the Trump administration’s cannabis rescheduling process plan to order cannabis from other states, what types of products they offer and who their suppliers are. That’s according to a list of 26 questions obtained by Marijuana Moment that agency officials are sending to businesses in Colorado that have filled out a DEA registration form for medical marijuana dispensaries. Once cannabis operators submit the form, DEA personnel stop by to inspect their facilities and generally have a number of follow-up questions that businesses need to submit answers to. Cannabis industry sources say the way the agency has been carrying out the inspection process varies between DEA’s regional offices throughout the country, however. The 26-item questionnaire that Marijuana Moment obtained is being used by DEA’s Rocky Mountain Division, which covers Colorado, Montana, Utah and Wyoming—though the latter state does not have legal medical cannabis. The questions on the form being sent to Colorado businesses include: Will you be ordering marijuana or marijuana products from other states? Will you be ordering synthetic cannabinoids? Will you be ordering marijuana seeds or plants in order to grow at the dispensary location? What are the specific types of products offered (e.g., gummies, extracts, concentrates, tinctures, topical products, oils, flower buds, oil cartridge vapes, dry herb vapes, pre-rolled cannabis cigarettes, etc.)? Please identify your medical marijuana supplier(s) to include name(s), address(es), and DEA registration number(s). Please provide a copy of any labeling, packaging, and sealing policies (refer to federal guidelines for medical marijuana packaging pursuant to Title 21 CFR § 1301.13(k)(8) which states that the label of all medical marijuana products shall, when dispensed to or for a patient, contain a clear, concise warning that it is a crime to transfer the drug to any person other than the patient). How is defective (e.g. mold, rot, bug infestation), expired, or discontinued/deadstock marijuana products disposed of? In June, Mississippi medical cannabis businesses spoke to Marijuana Moment about being visited by DEA officials, who told them they were among the first in the country to be seen for inspection under the registration process. The Mississippi businesses said DEA wanted similar questions answered, though there was not complete overlap with the Rocky Mountain list. For example, officials from DEA’s New Orleans division, which covers Mississippi, wanted information about any previous license transfers, state regulatory disciplinary history and security plans. While those items don’t appear specifically on the form being sent to Colorado businesses, it’s possible that agents are gathering that information in other ways, such as during their in-person visits. DEA’s press office did not respond to a request for comment from Marijuana Moment about why the agency has not standardized the process of handling medical marijuana business registration under rescheduling from region to region. The agency launched its initial registration form for dispensaries in April, days after Attorney General Blanche issued an order immediately moving marijuana products regulated by a state medical cannabis license from Schedule I of the Controlled Substances Act (CSA) to Schedule III, along with marijuana products that are approved by the Food and Drug Administration (FDA). A DEA hearing that recently concluded testimony is considering broader marijuana rescheduling. Meanwhile, the agency said it plans to launch new forms for additional types of state-licensed medical marijuana businesses beyond dispensaries, such as manufacturers, distributors and laboratories. The currently available registration form for state-licensed medical marijuana dispensaries asks for information about their processes for storage, ordering, dispensing, inventory, maintenance of records and other aspects of their businesses. The application asks about specific details about security measures such as vaults, safes, secure storage rooms, access controls, alarm systems and on-site security personnel. Applicants can choose whether they are requesting to handle marijuana, marijuana extracts or naturally derived delta-9 THC. While only medical marijuana is currently being moved to Schedule III, the application also asks potential registrants whether their firms handle or dispense recreational marijuana. The DEA application also asks businesses to submit information about their state cannabis licenses and to answer questions about criminal and disciplinary histories. It also asks: “Has anyone who will be involved in the ownership or operation of the firm previously manufactured, distributed, and/or dispensed any controlled substance without a DEA registration authorizing such activity?” Presumably, every currently operational state-legal cannabis business has key personnel who have done so, since medical marijuana was, until recently, a Schedule I controlled substance that DEA did not broadly authorize manufacturing, distribution and dispensation of. Applicants must additionally list suppliers from which they intend to procure marijuana, and to disclose whether they anticipate repackaging or relabeling cannabis products. They also need to provide lists of individuals with the business that are anticipated to have “access to controlled substances,” including their dates of birth, social security numbers, criminal histories related to drugs. Meanwhile, the U.S. Department of the Treasury and Internal Revenue Service (IRS) said they plan to issue new tax guidance for the marijuana industry following the rescheduling announcement. Rescheduling will benefit state-licensed marijuana businesses by allowing them to take federal tax deductions they’re currently barred from under an IRS code known as 280E that doesn’t apply to Schedule III substances. The Bureau of Alcohol, Tobacco, Firearms and Explosives (ATF) also recently posted a draft update to gun purchase form to acknowledge the federally legal status of medical marijuana under rescheduling. The Congressional Research Service published a report on the marijuana rescheduling move’s scope and limitations. Read the DEA’s list of questions for marijuana businesses below: The post DEA Has A List Of Questions For Marijuana Businesses That Register For Federal Rescheduling Protections appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

The whole arrangement was smooth from the first message till the end. She was stylish, friendly and knew exactly how to make the hours fly by. If you prefer sophisticated company, Russian Escort in Delhi is a solid choice that rarely lets you down.

After hearing a few good things I decided to try it. Russian Call Girl in Delhi delivered a smooth and classy evening. She was well-spoken, stylish, and made everything feel relaxed. Definitely better than average. Recommended.

Study: Medical marijuana for older adults; Marijuana rescheduling & business acquisition op-ed; MO hemp lawsuit; NM psilocybin apps Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day. Get our daily newsletter. Email address: Leave this field empty if you're human: Your support makes Marijuana Moment possible… Hold on, just one second before you read today’s news. Have you thought about giving some financial support to Marijuana Moment? If so, today would be a great day to contribute. We’re planning our reporting for the coming months and it would really help to know what kind of support we can count on. Check us out on Patreon and sign up to give $25/month today: https://www.patreon.com/marijuanamoment / TOP THINGS TO KNOW Colorado Gov. Jared Polis (D) pardoned more people for past marijuana convictions—adding to the thousands of such acts of cannabis clemency he has previously granted. “Not everyone earns the privilege of a second chance. But you have demonstrated that you deserve one.” A new study of people over the age of 65 who used medical cannabis found that “pain, insomnia, and mood or behavioral symptoms decreased significantly”—with “consistently low documented clinically effective doses.” “Symptom severity decreased significantly across the three main symptom domains, with improvement in approximately 90% of patients.” Christopher B. Lynch of Dickinson Wright PLLC argues in a new Marijuana Moment op-ed that federal rescheduling “is drawing interest from pharmaceutical, agricultural and consumer products companies” and that “well-positioned operators are already using this window to plan restructurings, seek new partners, acquire distressed assets and target new markets.” Florida Democrats are seizing on a grand jury report that found Gov. Ron DeSantis’s (R) administration “misappropriated” $10 million in Medicare funds for “political activities”—including opposing a marijuana legalization ballot initiative. Missouri officials and hemp businesses filed dueling briefs in a federal lawsuit from the industry that says the state’s new THC product restrictions are “unconstitutionally vague.” The New Mexico Department of Health is now accepting applications for medical psilocybin producer permits as regulators move to launch the program earlier than anticipated. Alabama’s second medical cannabis dispensary opened—about three months after sales launched at the first store, and five years after lawmakers passed legislation to legalize patient access. / FEDERAL The National Institute for Occupational Safety and Health published a report on cannabis industry worker safety. Rep. Riley Moore (R-WV) said he expects the House of Representatives to “iron out” some “sticking points” with a Senate-passed funding bill, “particularly the hemp issue.” The House bill to delay the federal recriminalization of hemp THC products got two new cosponsors for a total of 40. / STATES A Texas judge held a hearing on a request for a temporary restraining order to block hemp product restrictions. California regulators announced a recall of marijuana products due to incomplete and incorrect regulatory compliance testing. Illinois regulators clarified that there is no limit on the number of seeds that medical cannabis patients can purchase or possess. Maine regulators published guidance about outdoor medical cannabis cultivation. The Virginia Cannabis Control Authority Board of Directors will meet on September 9. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — / INTERNATIONAL St. Maarten lawmakers rejected a motion to release documents related to the government’s agreement with a firm helping to craft cannabis policies. / SCIENCE & HEALTH A study found that “Cannabis sativa crude extracts possess localised, low-potency inhibitory effects against MRSA.” A study of shelter-housed dogs with stress-related behaviors treated with CBD and CBDA found “increased resting, reduced locomotion and postural transitions, and fewer dogs displaying repetitive locomotion,” suggesting “a specific calming effect, potentially reflecting reduced nocturnal vigilance and reactivity, rather than generalized sedation.” / ADVOCACY, OPINION & ANALYSIS The New York Post editorial board criticized legislation to create a Cannabis Wage Board. / BUSINESS Glass House Brands Inc. rang the closing bell at the New York Stock Exchange. Canadian retailers sold C$517.8 million worth of legal marijuana products in June. / CULTURE Tennis player Katie Boulter complained about the smell of marijuana at the U.S. Open. Make sure to subscribe to get Marijuana Moment’s daily dispatch in your inbox. Get our daily newsletter. Email address: Leave this field empty if you're human: The post Colorado governor issues more cannabis pardons (Newsletter: August 31, 2026) appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Many thanks with regard to supplying current improvements concerning the issue, We anticipate study much more. sengtoto situs

Google love it play now

“The state is working really hard to operationalize this program as quickly as possible. People are suffering and they want to address that suffering.” By Leah Romero, Source NM New Mexico’s Medical Psilocybin Program recently opened up applications for producers of the psychedelic mushroom, marking a significant step toward the therapeutic program becoming fully operational. “We’re no longer talking about a piece of legislation and some rulemaking. This is real, this is happening and it’s being operationalized right now,” Santa Fe-based psychedelic attorney Victoria Cvitanovic told Source NM. The program was created last year with the signing of Senate Bill 219, which created the medical psilocybin program, an advisory board and legalized use of the psychedelic in controlled, therapeutic settings. Qualifying conditions currently include major treatment-resistant depression, post traumatic stress disorder, substance use disorders and end-of-life care. The New Mexico Department of Health Center for Medical Cannabis and Psilocybin began accepting applications last week from potential producers to grow the mushrooms for future program participants. Cvitanovic told Source that the application is intended to ensure the psilocybin “produced for this program in New Mexico is both safe and medically beneficial for patients, as well as that this doesn’t cause safety issues for people in New Mexico generally.” According to the permit requirements, applicants must provide a state business license; proof of registration with the New Mexico Secretary of State and the Taxation and Revenue Department; facility safety documents; proof of ownership of the facility or a signed statement from the landowner; proof of compliance with city and county zoning requirements; and verification that psilocybin products will only be produced and tested in New Mexico. “I think it’s notable that the application balances both the safety of the patients who will be receiving the end product and the safety of people who may live in areas of the state where someone is granted a license to produce psilocybin,” Cvitanovic said. “These applications are open to anyone, but they are fairly extensive because of the high stakes of producing a controlled substance, specifically for very limited medical use.” She said she believes that most applicants will have an agricultural and entrepreneurial background, but likely only a small number of “highly qualified” applications will meet the requirements. A DOH spokesperson told Source NM in an email that there is currently no deadline for applications and that they will be reviewed in order of submission. Cvitanovic said she recommends those considering applying to be a producer confer with a lawyer and accountant and get documentation together to submit the most complete and compliant application as possible. However, they should also consider whether their plans are operational if a permit is granted. SB219 set a deadline of December 31, 2027 for the psilocybin program to be implemented; however, the state committed to expediting the timeline by a year, aiming to open the program to its first patients by the end of 2026. “The state is working really hard to operationalize this program as quickly as possible,” Cvitanovic said. “People are suffering and they want to address that suffering.” She added that the program’s rulemaking process is not complete and more permit applications will open up down the line for testing and for qualified clinicians. A “buildout and inspection period” will also likely follow before treatment begins with patients. She encouraged people interested in participating in the program to speak with their behavioral health providers about becoming certified to facilitate the treatment. “Programs like this are only as strong as the clinicians and therapists and other people who choose to participate in them. This is hard work, and it is not risk free, but it has the ability to change the lives of thousands of New Mexicans who are suffering,” Cvitanovic said. This story was first published by Source NM. Photo courtesy of Alan Rockefeller. The post New Mexico Launches Medical Psilocybin Producer Permit Applications appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Great articles and great layout. Your blog post deserves all of the positive feedback it’s been getting. slot pestoto

This was a really great contest and hopefully I can attend the next one. It was alot of fun and I really enjoyed myself.. poker88